2024.03.21
CCH and Roche Diagnostics Asia Pacific Successfully Co-organized "AI on Clinical Decision Making and Precision Medicine Forum"
On March. 21, 2024. CCH worked with Roche Diagnostics Asia Pacific to co-organized the "AI on Clinical Decision Making and Precision Medicine Forum." Dr. Ching-Hsiung Lin, Vice Superintendent of CCH, and Mr. Christopher Chiam, APAC Digital Insights Value Stream Lead, Roche Diagnostics Asia Pacific, were invited to give the opening remarks. Dr. Tien-Hsiung Ku, Director of the Artificial Intelligence Development Center, and Dr. Hackman, Data Scientist of the Artificial Intelligence Development Center, shared the application and forecast in the Medical AI field. Dr. Ching-Min Lin, Division of General Thoracic Surgery of CCH, shared the transition of the lung cancer multidisciplinary team meeting with the navify® Tumor Board at CCH. Mr. Christopher Chiam, from APAC Digital Insights Value Stream Lead, Roche Diagnostics Asia Pacific, and Mr. Siddharth Zankat, from Technical Product Manager, Roche Information Solutions, shared Roche's oncology digital plan and cases. In this forum, the distinguished guests from various countries, including Singapore, Hong Kong, Malaysia, Vietnam, Thailand, India, Republic of Korea, Australia, and Argentina, also shared their experiences of how AI technology enhances the efficiency and accuracy of clinical decision-making. Around 80 participants joined and shared their feedback in the forum.